The Impact of Metformin in Pediatric Type-1 Diabetes Mellitus in Addition to Insulin Therapy; Literature Review

Alzahimah, Mohammed Abdullah and Sleem, Khalid Mohammed S. Al and Albenawy, Hatem Ahmed and Mushham, Albara Abdullah Mohammed Al (2021) The Impact of Metformin in Pediatric Type-1 Diabetes Mellitus in Addition to Insulin Therapy; Literature Review. Journal of Pharmaceutical Research International, 33 (41B). pp. 187-192. ISSN 2456-9119

[thumbnail of 3163-Article Text-4898-1-10-20221006.pdf] Text
3163-Article Text-4898-1-10-20221006.pdf - Published Version

Download (171kB)

Abstract

Background: Type 1 diabetes mellitus leads to significant cardiovascular risk through various mechanisms. Intensified insulin therapy is commonly required to achieve adequate glycemic control and reduce HbA1c. However, when insulin dose increases, it might increase insulin resistance and body weight, which directly affecting the cardiovascular profile.

Objective: We aim in this literature review to address the role of adding metformin to insulin therapy to limit the cardiovascular effect, insulin resistance and improve glycemic control in pediatric age.

Methods: We searched in the PubMed database for relevant articles using the following Mesh words: Metformin - Type 1 diabetes mellitus, pediatrics - Cardiovascular risk.

Conclusion: Metformin was found to has promising cardiovascular protection when adding to insulin therapy. However, the impact of metformin in type 1 diabetes mellitus glycemic control is controversial, and further multi-systemic randomized clinical trials are recommended to address this issue.

Item Type: Article
Subjects: Journal Eprints > Medical Science
Depositing User: Managing Editor
Date Deposited: 25 Mar 2023 12:45
Last Modified: 04 Jun 2024 10:51
URI: http://repository.journal4submission.com/id/eprint/1430

Actions (login required)

View Item
View Item